Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Language
Publication year range
1.
Mol Cell ; 50(2): 185-99, 2013 Apr 25.
Article in English | MEDLINE | ID: mdl-23523371

ABSTRACT

Tissue-specific differentiation programs become dysregulated during cancer evolution. The transcription factor Nkx2-1 is a master regulator of pulmonary differentiation that is downregulated in poorly differentiated lung adenocarcinoma. Here we use conditional murine genetics to determine how the identity of lung epithelial cells changes upon loss of their master cell-fate regulator. Nkx2-1 deletion in normal and neoplastic lungs causes not only loss of pulmonary identity but also conversion to a gastric lineage. Nkx2-1 is likely to maintain pulmonary identity by recruiting transcription factors Foxa1 and Foxa2 to lung-specific loci, thus preventing them from binding gastrointestinal targets. Nkx2-1-negative murine lung tumors mimic mucinous human lung adenocarcinomas, which express gastric markers. Loss of the gastrointestinal transcription factor Hnf4α leads to derepression of the embryonal proto-oncogene Hmga2 in Nkx2-1-negative tumors. These observations suggest that loss of both active and latent differentiation programs is required for tumors to reach a primitive, poorly differentiated state.


Subject(s)
Adenocarcinoma/metabolism , Cell Differentiation , Lung Neoplasms/metabolism , Nuclear Proteins/metabolism , Transcription Factors/metabolism , Adenocarcinoma/pathology , Animals , Binding Sites , Cell Proliferation , Cell Transformation, Neoplastic , Gastric Mucosa/metabolism , Gene Expression Regulation, Neoplastic , Hepatocyte Nuclear Factor 3-alpha/metabolism , Hepatocyte Nuclear Factor 3-beta/metabolism , Hepatocyte Nuclear Factor 4/genetics , Hepatocyte Nuclear Factor 4/metabolism , Humans , Hyperplasia/metabolism , Lung/metabolism , Lung/pathology , Lung Neoplasms/pathology , Mice , Mice, Transgenic , Mutation, Missense , Nuclear Proteins/genetics , Nuclear Proteins/physiology , Organ Specificity , Protein Binding , Proto-Oncogene Mas , Proto-Oncogene Proteins p21(ras)/genetics , Proto-Oncogene Proteins p21(ras)/metabolism , Pulmonary Alveoli/metabolism , Pulmonary Alveoli/pathology , Respiratory Mucosa/metabolism , Respiratory Mucosa/pathology , Stomach/pathology , Thyroid Nuclear Factor 1 , Transcription Factors/genetics , Transcription Factors/physiology , Transcriptional Activation , Transcriptome , Tumor Burden
2.
Proc Natl Acad Sci U S A ; 108(21): 8773-8, 2011 May 24.
Article in English | MEDLINE | ID: mdl-21555567

ABSTRACT

Activating K-RAS mutations are the most frequent oncogenic mutations in human cancer. Numerous downstream signaling pathways have been shown to be deregulated by oncogenic K-ras. However, to date there are still no effective targeted therapies for this genetically defined subset of patients. Here we report the results of a small molecule, synthetic lethal screen using mouse embryonic fibroblasts derived from a mouse model harboring a conditional oncogenic K-ras(G12D) allele. Among the >50,000 compounds screened, we identified a class of drugs with selective activity against oncogenic K-ras-expressing cells. The most potent member of this class, lanperisone, acts by inducing nonapoptotic cell death in a cell cycle- and translation-independent manner. The mechanism of cell killing involves the induction of reactive oxygen species that are inefficiently scavenged in K-ras mutant cells, leading to oxidative stress and cell death. In mice, treatment with lanperisone suppresses the growth of K-ras-driven tumors without overt toxicity. Our findings establish the specific antitumor activity of lanperisone and reveal oxidative stress pathways as potential targets in Ras-mediated malignancies.


Subject(s)
Neoplasms/drug therapy , Oxidative Stress/drug effects , ras Proteins , Animals , Antineoplastic Agents/pharmacology , Cell Death/drug effects , Cells, Cultured , Drug Evaluation, Preclinical , Fibroblasts/cytology , Mice , Neoplasms/metabolism , Neoplasms/pathology , Reactive Oxygen Species/agonists
3.
Proc Natl Acad Sci U S A ; 104(9): 3261-6, 2007 Feb 27.
Article in English | MEDLINE | ID: mdl-17360635

ABSTRACT

Tissue fusion, the morphogenic process by which epithelial sheets are drawn together and sealed, has been extensively studied in Drosophila. However, there are unique features of mammalian tissue fusion that remain poorly understood. Notably, detachment and apoptosis occur at the leading front in mammals but not in invertebrates. We found that in the mouse embryo, expression of the Nf2 tumor suppressor, merlin, is dynamically regulated during tissue fusion: Nf2 expression is low at the leading front before fusion and high across the fused tissue bridge. Mosaic Nf2 mutants exhibit a global defect in tissue fusion characterized by ectopic detachment and increased detachment-induced apoptosis (anoikis). By contrast with core components of the junctional complex, we find that merlin is required specifically for the assembly but not the maintenance of the junctional complex. Our work reveals that regulation of Nf2 expression is a previously unrecognized means of controlling adhesion at the leading front, thereby ensuring successful tissue fusion.


Subject(s)
Cell Adhesion/physiology , Embryo, Mammalian/embryology , Gene Expression Regulation, Developmental , Morphogenesis/physiology , Neurofibromin 2/metabolism , Animals , Apoptosis/physiology , DNA Primers , Embryo, Mammalian/metabolism , Embryo, Mammalian/ultrastructure , Epithelium/embryology , Immunohistochemistry , In Situ Hybridization , Mice , Mice, Transgenic , Microscopy, Electron, Transmission , Microscopy, Fluorescence
4.
Genes Dev ; 21(6): 694-707, 2007 Mar 15.
Article in English | MEDLINE | ID: mdl-17369402

ABSTRACT

Somatic activation of Ras occurs frequently in human cancers, including one-third of lung cancers. Activating Ras mutations also occur in the germline, leading to complex developmental syndromes. The precise mechanism by which Ras activation results in human disease is uncertain. Here we describe the phenotype of a mouse engineered to harbor a germline oncogenic K-rasG12D mutation. This mouse exhibits early embryonic lethality due to a placental trophoblast defect. Reconstitution with a wild-type placenta rescues the early lethality, but mutant embryos still succumb to cardiovascular and hematopoietic defects. In addition, mutant embryos demonstrate a profound defect in lung branching morphogenesis associated with striking up-regulation of the Ras/mitogen-activated protein kinase (MAPK) antagonist Sprouty-2 and abnormal localization of MAPK activity within the lung epithelium. This defect can be significantly suppressed by lentiviral short hairpin RNA (shRNA)-mediated knockdown of Sprouty-2 in vivo. Furthermore, in the context of K-rasG12D-mediated lung tumorigenesis, Sprouty-2 is also up-regulated and functions as a tumor suppressor to limit tumor number and overall tumor burden. These findings indicate that in the lung, Sprouty-2 plays a critical role in the regulation of oncogenic K-ras, and implicate counter-regulatory mechanisms in the pathogenesis of Ras-based disease.


Subject(s)
Genes, ras , Lung Neoplasms/genetics , Lung Neoplasms/metabolism , Lung/embryology , Membrane Proteins/metabolism , Adaptor Proteins, Signal Transducing , Animals , Base Sequence , Embryo Loss/genetics , Female , Gene Expression Regulation, Developmental , Gene Expression Regulation, Neoplastic , Germ-Line Mutation , Humans , Intracellular Signaling Peptides and Proteins , Lung/abnormalities , Lung/metabolism , Lung/pathology , Lung Neoplasms/pathology , MAP Kinase Signaling System , Membrane Proteins/deficiency , Membrane Proteins/genetics , Mice , Mice, Knockout , Mice, Transgenic , Pregnancy , Protein Serine-Threonine Kinases , RNA/genetics
5.
Genetics ; 173(2): 635-46, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16582437

ABSTRACT

In budding yeast, the essential roles of microtubules include segregating chromosomes and positioning the nucleus during mitosis. Defects in these functions can lead to aneuploidy and cell death. To ensure proper mitotic spindle and cytoplasmic microtubule formation, the cell must maintain appropriate stoichiometries of alpha- and beta-tubulin, the basic subunits of microtubules. The experiments described here investigate the minimal levels of tubulin heterodimers needed for mitotic function. We have found a triple-mutant strain, pac10Delta plp1Delta yap4Delta, which has only 20% of wild-type tubulin heterodimer levels due to synthesis and folding defects. The anaphase spindles in these cells are approximately 64% the length of wild-type spindles. The mutant cells are viable and accurately segregate chromosomes in mitosis, but they do have specific defects in mitosis such as abnormal nuclear positioning. The results establish that cells with 20% of wild-type levels of tubulin heterodimers can perform essential cellular functions with a short spindle, but require higher tubulin heterodimer concentrations to attain normal spindle length and prevent mitotic defects.


Subject(s)
Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/metabolism , Tubulin/chemistry , Tubulin/metabolism , Adaptor Proteins, Signal Transducing , Base Sequence , Chromosome Segregation , Chromosomes, Fungal/genetics , DNA, Fungal/genetics , Genes, Fungal , Lipoproteins/genetics , Lipoproteins/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mitosis/genetics , Mutation , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Phenotype , Protein Folding , Protein Structure, Quaternary , RNA, Fungal/genetics , RNA, Fungal/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/genetics , Spindle Apparatus/ultrastructure , Transcription Factors/genetics , Transcription Factors/metabolism , Tubulin/genetics
6.
Genetics ; 161(3): 983-94, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12136005

ABSTRACT

Cells expressing a mutant allele of alpha-tubulin, tub1-729, are cold sensitive and arrest as large-budded cells with microtubule defects. The cold sensitivity of tub1-729 is suppressed by extra copies of a subset of the mitotic checkpoint genes BUB1, BUB3, and MPS1, but not MAD1, MAD2, and MAD3. This suppression by checkpoint genes does not depend upon their role in the MAD2-dependent spindle assembly checkpoint. In addition, BUB1 requires an intact kinase domain as well as Bub3p to suppress tub1-729. The data suggest that tub1-729 cells are defective in microtubule-kinetochore attachments and that the products of specific checkpoint genes can act either directly or indirectly to affect these attachments.


Subject(s)
Saccharomyces cerevisiae/genetics , Spindle Apparatus/genetics , Tubulin/genetics , Alleles , Base Sequence , Chromosomes, Fungal/genetics , DNA Primers , Genes, Fungal , Genotype , Mitosis/genetics , Plasmids , Polymerase Chain Reaction , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/growth & development , Temperature
SELECTION OF CITATIONS
SEARCH DETAIL
...